Article Information
History
- February 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Vajeera Dorabawila, PhD1,*,
- Dina Hoefer, PhD1,
- Ursula E. Bauer, PhD1,
- Mary T. Bassett, MD1,
- Emily Lutterloh, MD1,2 and
- Eli S. Rosenberg, PhD1,2
- 1New York State Department of Health, Albany, New York
- 2University at Albany School of Public Health, State University of New York, Rensselaer, New York
- ↵*Corresponding author; email: vajeera.dorabawila{at}health.ny.gov
Posted February 28, 2022.
Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant
